Current issues in the management of actinic keratosis
- PMID: 23228304
- DOI: 10.1016/j.jaad.2012.09.051
Current issues in the management of actinic keratosis
Abstract
Actinic keratoses are common sun-induced skin lesions that should be treated to prevent the development of nonmelanoma skin cancer. Although cryotherapy is commonly used to treat individual lesions, it fails to address the actinically damaged field of neighboring sun-damaged skin, which is more effectively treated by field therapies to clear both visible and subclinical lesions. Most topical treatments require prolonged use and cause an inflammatory response that limits tolerability and adherence. Education is essential to teach patients about the chronic nature of actinic keratosis, the risk of nonmelanoma skin cancer, and the importance of correct use of topical medications. The addition of nonphysician clinicians to dermatologic practices provides a valuable source of education, treatment, and follow-up care to the management of actinic keratosis.
Copyright © 2012 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.
Similar articles
-
Topical management of actinic keratosis and field cancerisation.G Ital Dermatol Venereol. 2009 Aug;144(4):459-62. G Ital Dermatol Venereol. 2009. PMID: 19755950
-
Optimizing management of actinic keratosis and photodamaged skin: utilizing a stepwise approach.Cutis. 2009 Sep;84(3):169-75. Cutis. 2009. PMID: 19842577
-
The paradigm shift in treating actinic keratosis: a comprehensive strategy.J Drugs Dermatol. 2012 Dec;11(12):1462-7. J Drugs Dermatol. 2012. PMID: 23377517 Review.
-
[Diagnosis and treatment of actinic keratosis].Duodecim. 2015;131(9):863-70. Duodecim. 2015. PMID: 26237885 Review. Finnish.
-
Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis.J Am Acad Dermatol. 2009 Jun;60(6):934-43. doi: 10.1016/j.jaad.2009.01.008. J Am Acad Dermatol. 2009. PMID: 19467365 Clinical Trial.
Cited by
-
Skin cancer precursor immunotherapy for squamous cell carcinoma prevention.JCI Insight. 2019 Mar 21;4(6):e125476. doi: 10.1172/jci.insight.125476. eCollection 2019 Mar 21. JCI Insight. 2019. PMID: 30895944 Free PMC article. Clinical Trial.
-
Thickness of Actinic Keratosis Does Not Predict Dysplasia Severity or P53 Expression.Sci Rep. 2016 Sep 27;6:33952. doi: 10.1038/srep33952. Sci Rep. 2016. PMID: 27670104 Free PMC article.
-
Actinic Keratoses (AK): An Exploratory Questionnaire-Based Study of Patients' Illness Perceptions.Curr Oncol. 2022 Jul 21;29(7):5150-5163. doi: 10.3390/curroncol29070408. Curr Oncol. 2022. PMID: 35877268 Free PMC article.
-
Patient satisfaction and reported outcomes on the management of actinic keratosis.Clin Cosmet Investig Dermatol. 2017 May 17;10:179-184. doi: 10.2147/CCID.S121323. eCollection 2017. Clin Cosmet Investig Dermatol. 2017. PMID: 28553130 Free PMC article. Review.
-
Review of Clinical Evidence over 10 Years on Prevention and Treatment of a Film-Forming Medical Device Containing Photolyase in the Management of Field Cancerization in Actinic Keratosis.Dermatol Ther (Heidelb). 2019 Jun;9(2):259-270. doi: 10.1007/s13555-019-0294-1. Epub 2019 Apr 9. Dermatol Ther (Heidelb). 2019. PMID: 30968311 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources